These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 26771676

  • 21. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy.
    Hamai Y, Emi M, Ibuki Y, Murakami Y, Nishibuchi I, Nagata Y, Kurokawa T, Yoshikawa T, Hirohata R, Ohsawa M, Kitasaki N, Okada M.
    Surgery; 2022 Aug; 172(2):584-592. PubMed ID: 35523595
    [Abstract] [Full Text] [Related]

  • 22. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Cancer; 2004 Oct 15; 101(8):1776-85. PubMed ID: 15386332
    [Abstract] [Full Text] [Related]

  • 23. Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
    Tan S, Kligerman S, Chen W, Lu M, Kim G, Feigenberg S, D'Souza WD, Suntharalingam M, Lu W.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):1375-82. PubMed ID: 23219566
    [Abstract] [Full Text] [Related]

  • 24. Potential values of metabolic tumor volume and heterogeneity measured with ¹⁸F-FDG PET/CT pretreatment to evaluate local control for esophageal squamous cell carcinoma treated with nonsurgical therapy.
    Liu Q, Fu XL, Yu W, Zhu ZF, Zhang YJ.
    Nucl Med Commun; 2015 May 01; 36(5):423-9. PubMed ID: 25603275
    [Abstract] [Full Text] [Related]

  • 25. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Lee SJ, Kim JG, Lee SW, Chae YS, Kang BW, Lee YJ, Park JS, Choi GS.
    Cancer Chemother Pharmacol; 2013 May 01; 71(5):1201-7. PubMed ID: 23420438
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chan DS, Fielding P, Roberts SA, Reid TD, Ellis-Owen R, Lewis WG.
    Clin Radiol; 2013 Apr 01; 68(4):352-7. PubMed ID: 22981727
    [Abstract] [Full Text] [Related]

  • 27. Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation.
    Arnett ALH, Merrell KW, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL.
    J Thorac Oncol; 2017 Jan 01; 12(1):121-128. PubMed ID: 27569732
    [Abstract] [Full Text] [Related]

  • 28. Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.
    Hong JH, Kim HH, Han EJ, Byun JH, Jang HS, Choi EK, Kang JH, Yoo IeR.
    J Korean Med Sci; 2016 Jan 01; 31(1):39-46. PubMed ID: 26770036
    [Abstract] [Full Text] [Related]

  • 29. The early predictive value of a decrease of metabolic tumor volume in repeated (18)F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy.
    Huang W, Liu B, Fan M, Zhou T, Fu Z, Zhang Z, Li H, Li B.
    Eur J Radiol; 2015 Mar 01; 84(3):482-488. PubMed ID: 25533718
    [Abstract] [Full Text] [Related]

  • 30. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D, Lee JE, Huh SJ, Park W, Nam H, Choi JY, Kim BT.
    Int J Radiat Oncol Biol Phys; 2013 Nov 01; 87(3):549-54. PubMed ID: 24074928
    [Abstract] [Full Text] [Related]

  • 31. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC.
    J Nucl Med; 2013 Oct 01; 54(10):1703-9. PubMed ID: 24042030
    [Abstract] [Full Text] [Related]

  • 32. Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET/CT in patients with surgically resected rectal cancer.
    Jo HJ, Kim SJ, Lee HY, Kim IJ.
    Clin Nucl Med; 2014 Jun 01; 39(6):493-7. PubMed ID: 24806602
    [Abstract] [Full Text] [Related]

  • 33. Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer.
    Kim N, Cho H, Yun M, Park KR, Lee CG.
    Radiat Oncol; 2019 Feb 04; 14(1):27. PubMed ID: 30717809
    [Abstract] [Full Text] [Related]

  • 34. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Jeong Y, Kim JH, Kim SB, Yoon DH, Park SI, Kim YH, Kim HR, Jung HY, Lee GH, Ryu JS.
    J Surg Oncol; 2014 Apr 04; 109(5):472-7. PubMed ID: 24301552
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ, Chung CS, Wu YW, Yen RF, Cheng MF, Lee JM, Hsu CH, Chang YL, Wang HP.
    Dis Esophagus; 2012 Jan 04; 25(1):40-7. PubMed ID: 21595776
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, Choi Y, Choe YS, Kim BT.
    J Nucl Med; 2004 Nov 04; 45(11):1843-50. PubMed ID: 15534053
    [Abstract] [Full Text] [Related]

  • 39. Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.
    Chen SW, Hsieh TC, Ding HJ, Yen KY, Lin CY, Liang JA, Kao CH.
    Nucl Med Commun; 2014 Mar 04; 35(3):291-7. PubMed ID: 24276528
    [Abstract] [Full Text] [Related]

  • 40. [Prognostic value of the metabolically active tumour volume].
    Paumier A, Marquis A, Trémolières P, Lacombe M, Capitain O, Septans AL, Peyraga G, Gustin P, Vénara A, Ménager É, Visvikis D, Couturier O, Rio E, Hatt M.
    Cancer Radiother; 2016 Feb 04; 20(1):24-9. PubMed ID: 26762703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.